CATABASIS PHARMACEUTICALS INC of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-11-15. The offering totals $32.4M, of which $32.4M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 31 people.
| Name | Role | Location |
|---|---|---|
| Nicholas Galakatos | Director | New York, NY |
| Ron Laufer | Director | Gaithersburg, MD |
| Jill Milne | Director | Cambridge, MA |
| Michael Ross | Director | South San Francisco, CA |
| Michael Jirousek | Executive Officer | Cambridge, MA |
| Jill Milne | Executive Officer | Cambridge, MA |
| Joanne T Beck | Director | LONDON, X0 |
| Jeffrey Leiden | Director | Rochester, NY |
| Jill C Milne | Director | Boston, MA |
| Jill C Milne | Executive Officer | Boston, MA |
| Joanne C Donovan | Executive Officer | Boston, MA |
| Andrew C Nichols | Executive Officer | Boston, MA |
| Andrew C Komjathy | Executive Officer | Boston, MA |
| Michael D Kishbauch | Director | Boston, MA |
| Kenneth D Bate | Director | Boston, MA |
| Hugh T Cole | Director | Boston, MA |
| Gregg T Lapointe | Director | Boston, MA |
| Jonathan T Violin | Director | Boston, MA |
| Fred T Callori | Director | Boston, MA |
| Noah T Clauser | Executive Officer | Boston, MA |
| Ben T Harshbarger | Executive Officer | Boston, MA |
| Michael C Ross | Director | Spencer, MA |
| Chris Thomajan | Executive Officer | Belmont, MA |
| Ron C Laufer | Director | Cambridge, MA |
| Kenneth C Bate | Director | Cambridge, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2021-02-08 | D | $110.0M | $110.0M |
| 2021-02-08 | D | $175.7M | $175.7M |
| 2015-03-31 | D | $20.4M | $12.4M |
| 2013-06-27 | D/A | $9.2M | $9.2M |
| 2013-02-01 | D | $8.7M | $8.7M |
| 2010-04-14 | D | $39.7M | $7.7M |
| 2010-01-15 | D/A | $3.0M | $2.1M |
| 2009-05-12 | D/A | $2.0M | $1.1M |
| 2009-04-07 | D/A | $1.0M | $1.0M |